Psoriatic Arthritis
📧 Sign up to get email alerts when something new happens for Psoriatic Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-08-22Clinical Trial Update: A Study of Ixekizumab (LY2439821) in Participants Aged ≥18 Years With Moderate-to-Severe Plaque or Active Psoriatic Arthritis in India [Phase 4]
A Phase 4 study evaluating ixekizumab for adults with plaque psoriasis or psoriatic arthritis in India has completed, with results posted.
-
CLINICAL_TRIALS research · 2025-08-20Clinical Trial Update: Molecular Inflammation Board at the Center for Personalized Medicine
A University Hospital Tuebingen clinical trial is recruiting for a personalized medicine program targeting psoriasis, psoriatic arthritis, i…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: INSELMA - a Randomised Controlled Trial [NA]
INSELMA is a randomized controlled trial that is currently recruiting for rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthr…
-
CLINICAL_TRIALS trial_result · 2025-08-17Clinical Trial Update: Study to Assess the Safety and Change in Disease Symptoms of Risankizumab (Skyrizi) in Adult Participants With Moderate to Severe Plaque Psoriasis and Psoriatic Arthritis
This clinical trial update reports safety findings and changes in disease symptoms for risankizumab (Skyrizi) in adults with moderate-to-sev…
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: COMFI - a COMbined Fatigue Intervention [NA]
Clinical trial COMFI is evaluating a combined fatigue intervention for inflammatory arthritis conditions and is currently recruiting partici…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-08-14FDA Approved: OTULFI — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for OTULFI (ustekinumab-AAUZ) from Fresenius Kabi USA, LLC.
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: IKBKB Gene Polymorphism (Single Nucleotide Polymorphism) (SNP) in Psoriatic and Psoriatic Arthritis Patients [NA]
A completed clinical trial evaluated the IKBKB gene polymorphism (SNP) in patients with psoriasis and psoriatic arthritis.
-
EMA approval · 2025-08-13EMA Authorised: Enbrel (etanercept) — Pfizer Europe MA EEIG
The European Medicines Agency authorised Enbrel (etanercept) for multiple inflammatory diseases including rheumatoid arthritis, ankylosing s…
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial [Phase 4]
This document outlines a Phase 4 pragmatic randomized controlled trial evaluating glucagon-like peptide-1 (GLP-1) analogs for disease outcom…
-
FDA approval · 2025-07-29FDA Approved: ADALIMUMAB — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Sandoz Inc for the adalimumab biosimilar ADALIMUMAB-ADAZ, enabling its use with indications cons…
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Typological Study of Sleep Pathologies During Psoriatic Rheumatism and SAPHO Syndrome: Prospective Study Within the Paris Saint-Joseph Hospital Group"
A prospective typological study investigating sleep pathologies in psoriatic arthritis and SAPHO syndrome, sponsored by Fondation Hôpital Sa…
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Genetic Variation in TRAF3IP2 (rs13190932) [NA]
A clinical trial is investigating the genetic variation TRAF3IP2 rs13190932 in participants with psoriasis and psoriatic arthritis. The stud…
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: Open Label Study of the Effects of Secukinumab on Nail Psoriasis and Non-Invasive Measures of Enthesitis (Phase IV) [Phase 4]
Open-label Phase IV study evaluating secukinumab for nail psoriasis and enthesitis in psoriasis patients has completed.
-
EMA approval · 2025-07-17EMA Authorised: Nordimet (methotrexate) — Nordic Group B.V.
EMA authorised Nordimet (methotrexate) by Nordic Group B.V. for use in arthritis-related conditions including rheumatoid arthritis, psoriati…
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications
A clinical trial assessing pregnancy outcomes in risankizumab-exposed pregnancies versus non-exposed pregnancies in women with FDA-approved …
-
CLINICAL_TRIALS trial_result · 2025-07-14Clinical Trial Update: Artificial Intelligence Literacy and E-Health Literacy in Rheumatic Diseases
A completed clinical trial evaluating artificial intelligence literacy and e-health literacy in people with rheumatic diseases, including rh…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Influence of Sodium Intake in spondyLoarthriTes [NA]
A clinical trial is investigating the effect of sodium intake on disease activity in axial spondyloarthritis and psoriatic arthritis and is …
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: Clinical Study of Efficacy and Safety of BCD-085 (Monoclonal Anti-IL-17 Antibody) in Psoriatic Arthritis [Phase 3]
Biocad's monoclonal anti-IL-17 antibody BCD-085 completed a Phase 3 study evaluating efficacy and safety in psoriatic arthritis.
-
CLINICAL_TRIALS research · 2025-07-04Clinical Trial Update: Personalized Outreach for Equitable Treatment in Rheumatology [NA]
A University of British Columbia–sponsored clinical trial aimed at personalized outreach for equitable treatment in rheumatic diseases, curr…
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: A Study to Evaluate the Safety and Tolerability, and the Efficacy of Si-544 in Adults With Psoriasis Vulgaris or Psoriatic Arthritis [Phase 1]
A Phase 1 study evaluating safety, tolerability, and preliminary efficacy of Si-544 in adults with psoriasis vulgaris or psoriatic arthritis…
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: Right Ventricular Strain in Detecting Subclinical Right Ventricular Systolic Dysfunction in Psoriatic Arthritis Patients: Relation to Serum Endostatin Level
A clinical trial sponsored by Ain Shams University is investigating whether right ventricular strain can detect subclinical right ventricula…
-
FDA label_change · 2025-06-27FDA Approved: USTEKINUMAB — Supplemental Application (Janssen Biotech, Inc.)
FDA approves a supplemental application for Ustekinumab (Stelara) by Janssen Biotech, resulting in updated labeling.
-
CLINICAL_TRIALS trial_result · 2025-06-27Clinical Trial Update: Ten-Year Biologic Drug Survival in Psoriasis: Role of Genetic and Cardiometabolic Predictors
A completed clinical study evaluating ten-year persistence of biologic therapies in psoriasis and psoriatic arthritis and how genetic and ca…
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: Golimumab Safety and Surveillance Program Using the Ingenix NHI Database
This document reports the completion of a safety surveillance trial for golimumab using the Ingenix NHI database to monitor safety in rheuma…
-
EMA approval · 2025-06-24EMA Authorised: Zessly (infliximab) — Sandoz GmbH
EMA authorised Zessly (infliximab) from Sandoz GmbH as a biosimilar for treatment of several inflammatory diseases, including rheumatoid art…